Cancer Research: RGCC Greece Test & Cancer Stem Cells

 

STEP ONE

Be informed.  Read information below.

STEP TWO

Schedule test & interpretation with R. Douglas Wichman, MD.

STEP THREE

Submit "New Patient Form", current labwork, & imaging results prior to interpretation.

STEP FOUR

Establish if you are a candidate for therapy

in accordance with the Georgia

"Access to Medical Treatment Act".

 

--------------------------------------------------------------------------------------------------------------------------------

*** SPECIAL NOTE FROM DR. WICHMAN ***

WE OFFER THIS TEST to evaluate your Intravenous (IV) therapy options.  Beware of certain other doctors who use this test to "sell you supplements".  In a real human, ORAL supplementation cannot achieve the tissue concentration necessary to kill cancer cells.  By challenging your cancer but failing to kill it, these other doctors are in fact promoting resistance to their own therapy!

----------------------------------------------------------------------------------------------------------------------------------------------------------

 

Using the latest breakthroughs in molecular biology, The Greece Test can test the blood for malignant tumor cells and assess the patient’s sensitivity to chemotherapy.

The Greece Test Benefits:
  • Studies cancer cells without invasive biopsy procedures.
  • Tests are performed on the cancer cells themselves, not a subclone.
  • Tests the viability of anti-cancer chemotherapy drugs and the patient’s ability to metabolize them.
  • Identifies cancer cell mutations that can cause resistance to therapies.
  • Testing of natural substances which may be used to support conventional oncology treatments.

Since the Human Genome Project sequenced human DNA, many in the medical community hoped this breakthrough could help diagnose and treat common human diseases, like cancer. Fortunately, new cancer tests have arrived which can help doctors develop a precise treatment.

Using the latest breakthroughs in genetic therapy, The Greece Cancer Test can be used to isolate tumor cells in the bloodstream, culture them for further diagnosis, assess the patient’s sensitivity to chemotherapy, and then develop a profile of the cancer. Using those results, a personalized treatment program can be designed for the individual patient, instead of using a “hit-and-miss” approach using known cancer drugs.

 

 

How The Greece Test Works:
how-cancer-spreads-2

Cancer spreading through the circulatory system.

In addition, these circulating tumor cells can be used to assess the patient’s ability to metabolize chemotherapy drugs and assess the tumor’s resistivity to treatment. Their result is a more informed treatment procedure crafted for the patient.

Cancer cells travel the circulatory system along with the other blood cells. A medical professional takes a blood sample in the office. The sample is then sent to R.G.C.C. International GmbH, a European genetic research center. They create blood culture and isolate the tumor cell and perform a series of tests are given such as micro-array, PCR, RT-PCR, southern and less northern blot.

Based on the results, the medical practitioner can do the following:

  • Discover genes which aid cancer growth.
  • Assess which mechanisms that causes the body to resist chemotherapy drugs, and seek chemotherapy drugs that can aid the patient’s recovery.
  • Assess which nutrients can cause apoptosis, tumor cell death, and slow cancer cell growth.
  • Develop a natural treatment program to hasten recovery.

* The A.R.I. Research Pipeline *

We are seeking INVESTORS for an on-site, 

state-of-the-art Circulating Tumor Cell (CTC)

harvesting system to replace the "other" tests:

 

  • superior enumeration technology
  • faster turnaround
  • lower cost
  • in-hand "liquid biopsies"
  • PATIENT-SPECIFIC breakthroughs → targeted infusions, oncolytic viruses, dendritic vaccines

 

                      I N T E R E S T E D ?


TERMS:

  • we seek a total investment of $50,000; the minimum participation level will be $5000
  • we anticipate running ~5 CTC counts per week (~250 counts per year)
  • fixed costs are one $100 cartridge + ~$50 in labor/supplies per count = ~$150 per count
  • an extremely competitive price would be $350 per count, yielding a NET profit of ~$200 per count (~$50,000 per year)
  • therefore, we anticipate recovering the total investment in ~1 year
  • the investor pool shall receive 100% of NET profits from CTC counts until the total investment has been recovered
  • afterwards, the investor pool shall receive 25% of NET profits from CTC counts for an additional 3 years
  • of course, all CTC count results and all harvested cells shall remain the property of A.R.I.

Hyperbaric Oxygen Therapy

 

Hyperbaric Oxygen Therapy (HBOT) helps all kinds of people. It’s used to help patients suffering from sports injuries, Chronic Fatigue Syndrome, infections, arthritis and a huge range of other medical conditions. As we all know, oxygen is vital for life, and life cannot exist without it. It follows that oxygen is essential for effective healing and recovery.

read more

Book Your Appointment NOW

Call (770) 232-7883

 

Click to E-Mail Us Now!

 

Our Address:

4488 N. Shallowford Road, Suite 201

Dunwoody, Georgia 30338

 

We Serve the Following Areas:

Atlanta, Georgia, Acworth, Alpharetta, Berkeley Lake, Braselton, Brookhaven, Buckhead, Buford, Canton, Chamblee, Conyers, Cumming, Dacula, Decatur, Doraville, Duluth, Dunwoody, Georgia, Flowery Branch, Gainesville, Grayson, Hoschton, Johns Creek, Kennesaw, Lawrenceville, Lilburn, Lithonia, Loganville, Marietta, Milton, Norcross, Roswell, Sandy Springs, Smyrna, Snellville, Stone Mountain, Sugar Hill, Suwanee, Tucker, Vinings, Woodstock, Georgia